NCT05252598View on ClinicalTrials.gov

Mood and Cognitive Effects of Psilocybin in Healthy Participants

EARLY_PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2023

Primary Completion Date

August 31, 2023

Study Completion Date

December 31, 2023

Conditions
Mood DisturbanceMood ChangeSleep DisturbanceDrug EffectPsychedelic ExperiencesHealth, SubjectivePsilocin ToxicityPsilocybin ToxicityPsilocybin Causing Adverse Effects in Therapeutic UseAnxiety
Interventions
DRUG

Psilocybin

1mg encapsulated psilocybin

DRUG

Inonotus Obliquus Whole Extract

1mg encapsulated chaga mushroom

Sponsors
All Listed Sponsors
collaborator

University of Calgary

OTHER

lead

Optimi Health Corporation

INDUSTRY